Prevalence of pain-related single nucleotide polymorphisms in patients of African origin with sickle cell disease

Pharmacogenomics

Volumn 16, Issue 16, 2015, Pages 1795-1806

  Jhun, Ellie H ^a   Yao, Yingwei ^a,b   He, Ying ^a   Kyle, MacK A ^c,d,e   Wilkie, Diana J ^a,b   Molokie, Robert E ^a   Wang, Zaijie Jim ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF NURSING   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

^e JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

African American; genotype; pain; pharmacogenomics; polymorphisms; population; sickle cell disease; SNPs

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PREVALENCE; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ANEMIA, SICKLE CELL; GENETICS; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; ANEMIA, SICKLE CELL; CHILD; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; PAIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; YOUNG ADULT;

EID: 84947905448     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.15.126     Document Type: Article

References (36)

1. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 376(9757), 2018-2031 (2010).
2. Platt OS, Thorington BD, Brambilla DJ et al. Pain in sickle cell disease. Rates and risk factors. N. Engl. J. Med. 325(1), 11-16 (1991).
3. Kanter J, Kruse-Jarres R. Management of sickle cell disease from childhood through adulthood. Blood Rev. 27(6), 279-287 (2013).
4. Wilkie DJ, Molokie R, Boyd-Seal D et al. Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease. J. Natl Med. Assoc. 102(1), 18-27 (2010).
5. Smith WR, Scherer M. Sickle-cell pain: advances in epidemiology and etiology. Hematology Am. Soc. Hematol. Educ. Program 2010, 409-415 (2010).
6. Ballas SK, Gupta K, Adams-Graves P. Sickle cell pain: a critical reappraisal. Blood 120(18), 3647-3656 (2012).
7. Jhun E, He Y, Yao Y et al. Dopamine D3 receptor Ser9Gly and catechol-O-methyltransferase Val158Met polymorphisms and acute pain in sickle cell disease. Anesth. Analg. 119(5), 1201-1207 (2014).
8. Shord SS, Cavallari LH, Gao W et al. The pharmacokinetics of codeine and its metabolites in Blacks with sickle cell disease. Eur. J. Clin. Pharmacol. 65(7), 651-658 (2009).
9. Lettre G, Sankaran VG, Bezerra MA et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc. Natl Acad. Sci. USA 105(33), 11869-11874 (2008).
10. Mendonca TF, Oliveira MC, Vasconcelos LR et al. Association of variant alleles of MBL2 gene with vasoocclusive crisis in children with sickle cell anemia. Blood Cells Mol. Dis. 44(4), 224-228 (2010).
11. Belfer I, Youngblood V, Darbari DS et al. A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia. Am. J. Hematol. 89(2), 187-193 (2014).
12. Steinberg MH, Sebastiani P. Genetic modifiers of sickle cell disease. Am. J. Hematol. 87(8), 795-803 (2012).
13. National Heart, Lung, And Blood Institute. Disease and conditions index. Sickle cell anemia: who is at risk www.nhlbi.nih.gov
14. Ezenwa MO, Molokie RE, Wang ZJP et al. Outpatient pain predicts subsequent one-year acute health care utilization among adults with sickle cell disease. J. Pain Symptom Manage. 48(1), 65-74 (2014).
15. Krashin D, Murinova N, Ballantyne J. Management of pain with comorbid substance abuse. Curr. Psychiatry Rep. 14(5), 462-468 (2012).
16. Sharp J, Keefe B. Psychiatry in chronic pain: a review and update. Curr. Psychiatry Rep. 7(3), 213-219 (2005).
17. Bergen AW, Kokoszka J, Peterson R et al. Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol. Psychiatry 2(6), 490-494 (1997).
18. Van Esch AA, Lamberts MP, Te Morsche RH et al. Polymorphisms in gene encoding TRPV1-receptor involved in pain perception are unrelated to chronic pancreatitis. BMC Gastroenterol. 9 97 (2009).
19. Balding DJ. A tutorial on statistical methods for population association studies. Nat. Rev. Genet. 7(10), 781-791 (2006).
20. Shankar SM, Arbogast PG, Mitchel E et al. Medical care utilization and mortality in sickle cell disease: a populationbased study. Am. J. Hematol. 80(4), 262-270 (2005).
21. Ballas SK. Pain management of sickle cell disease. Hematol. Oncol. Clin. North Am. 19(5), 785-802 (2005).
22. Hapmap. International HapMap Project. HapMap data release 28 Phase II + III August 10 on NCBI B36 assembly dbSNP b126 (2010). http://hapmap.ncbi.nlm.nih.gov
23. Flicek P, Ahmed I, Amode MR et al. Ensembl 2013. Nucleic Acids Res. 41, D48-D55 (2013).
24. Joly P, Gagnieu MC, Bardel C et al. Genotypic screening of the main opiate-related polymorphisms in a cohort of 139 sickle cell disease patients. Am. J. Hematol. 87(5), 534-536 (2012).
25. Parra EJ, Marcini A, Akey J et al. Estimating African-American admixture proportions by use of population-specific alleles. Am. J. Hum. Genet. 63(6), 1839-1851 (1998).
26. Marsh S, King CR, Van Booven DJ et al. Pharmacogenomic assessment of Mexican and Peruvian populations. Pharmacogenomics 16(5), 441-448 (2015).
27. Price AL, Patterson NJ, Plenge RM et al. Principal components analysis corrects for stratification in genomewide association studies. Nat. Genet. 38(8), 904-909 (2006).
28. Roeder K, Luca D. Searching for disease susceptibility variants in structured populations. Genomics 93(1), 1-4 (2009).
29. Prestes AP, Marques FZ, Hutz MH et al. Tobacco smoking and the ADRA2A C-1291G polymorphism. J. Neural Transm. 114(11), 1503-1506 (2007).
30. Sickert L, Muller DJ, Tiwari AK et al. Association of the alpha 2A adrenergic receptor-1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans. Pharmacogenomics 10(7), 1169-1176 (2009).
31. Lochman J, Balcar VJ, Stastny F, Sery O. Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 genes. Psychiatry Res. 205(1-2), 7-12 (2013).
32. Delgado PL. Common pathways of depression and pain. J. Clin. Psychiatry 65(Suppl. 12), 16-19 (2004).
33. Wood PB. Role of central dopamine in pain and analgesia. Expert Rev. Neurother. 8(5), 781-797 (2008).
34. Rosenberg MB, Carroll FI, Negus SS. Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats. J. Pain 14(3), 246-259 (2013).
35. Brederson JD, Kym PR, Szallasi A. Targeting TRP channels for pain relief. Eur. J. Pharmacol. 716(1-3), 61-76 (2013).
36. Wright J, Ahmedzai SH. The management of painful crisis in sickle cell disease. Curr. Opin. Support. Palliat. Care 4(2), 97-106 (2010).